Cormorant Reports a $10 Million EYPT Buy

Steve Strazza
December 12, 2023

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a Form 4 filing by Cormorant Asset Management LP.

The investment firm reported the acquisition of 588,235 shares of EyePoint Pharmaceuticals Inc $EYPT, equivalent to roughly $10 million.

Article Sales Message

Know the trading behavior of …

  • Senators
  • House Of Representatives
  • C-Suite Executives
  • Hedge Fund Managers
  • Other Big-Power Players

Our experienced team of analysts work through the Form 4, 13D and 13G filings to provide you a list of the best trade ideas.

You need to have a subscription to access this content in full.

Log in or subscribe
Filed Under: